Search

Although cocaine craving can persist for weeks after the last use and is thought to play a role in future relapses, few short, reliable, and valid instruments exist to measure craving. Therefore, we wished to examine the validity of the 4-item Voris Cocaine Craving Scale (VCCS), which was previously found reliable. A consecutive series of 41 recently withdrawn cocaine-dependent patients completed the 4-item VCCS and the Cocaine Craving Questionnaire (CCQ), which was used as the criterion measure. The VCCS items 1 'craving,' 2 'mood,' and 3 'health' were significant and highly correlated with the CCQ total craving score. The VCCS may prove to be useful in future outcome studies involving cocaine craving and in routine clinical treatment.

Fifteen male veteran cocaine addicts took simple tests of cocaine craving, mood, energy, and perceived health status for 23 consecutive days during an inpatient treatment center. Results show they experienced very little cocaine craving or other symptomatology. Multiple regression analyses show that health rating alone was the best predictor of cocaine craving. These results question solely internal sources of craving and the oft-touted craving-depression connection. The study delineates further implications of the findings.

Blood and urine tests are only capable of detecting recent cocaine use. Since cocaine is deposited in the hair, a method was tested for its ability to detect past cocaine use from analysis of hair. The levels of benzoylecgonine, a product of cocaine breakdown, were measured in the hair of 16 adults whose urine tests were negative for cocaine. The levels of the cocaine metabolite were higher in heavy cocaine users than in occasional users. Although cocaine was detected in the hair of newborns whose mothers used cocaine, the drug could not be detected in the hair of infants of one year and older because they had lost their fetal hair. The detection of cocaine by hair analysis may prove to be beneficial in determining prenatal exposure to cocaine when the maternal drug history is either unavailable or dubious. This test may also prove to be helpful in studies of reproductive risks of cocaine because it can accurately identify exposed and nonexposed populations in certain age groups., ABSTRACT: Drug self-reports are often unreliable and standard blood and urine tests detect only recent cocaine use. Since cocaine is deposited in hair, we have applied a radioimmunoassay to hair extract to detect past cocaine use. Hair from 16 adult users was positive for benzoylecgonine, in the presence of negative findings from urine screening tests. Benzoylecgonine in admitted heavy users averaged 8775 ng/g of hair (range, 640 to 29089 ng/g of hair), whereas in occasional users it averaged 624 ng/g of hair (range, 32 to 1210 ng/g of hair). Benzoylecgonine was not detected in hair of 21 adults who reported no use of cocaine ever and whose urine samples were negative for the metabolite. Neonatal hair from seven infants whose mothers were known cocaine users averaged 5430 ng of benzoylecgonine per gram of hair (range, 200 to 27500 ng/g of hair). Hair from two infants 2.5 and 3.5 months of age averaged 6050 ng of benzoylecgonine per gram of hair. However, values were negative for infants 1 year and older, corresponding to loss of fetal hair in the few months after birth. Because studies reporting reproductive risks of cocaine compare exposed and nonexposed groups, validation of drug-free status of control subjects is extremely important. Hair analysis may remedy the disadvantages of currently used methods and may identify intrauterine exposure to cocaine in babies when a maternal drug history is not available or of doubtful truthfulness.